Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 5
- Share change
- -4,743,321
- Total reported value
- $1,000
- Price per share
- $200.00
- Number of holders
- 1
- Value change
- -$1,914,000
- Number of sells
- 24
Report period
Q3 2022
Institutions
1
Top holders
1
CLRB full security history
Newer quarter: Q1 2023
Previous quarter: Q2 2022
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
21%
|
1,837,046
|
$1,625,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
20%
|
1,753,800
|
$708,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
574,218
|
$232,000 | — | 30 Jun 2022 | |
| Worth Venture Partners, LLC |
13F
|
Company |
5.3%
|
458,245
|
$225,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
444,415
|
$179,000 | — | 30 Jun 2022 | |
| Maven Securities LTD |
13F
|
Company |
4.6%
|
400,000
|
$162,000 | — | 30 Jun 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
217,500
|
$88,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.9%
|
166,500
|
$67,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
157,146
|
$63,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
121,107
|
$49,000 | — | 30 Jun 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
103,644
|
$42,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
95,438
|
$39,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.79%
|
68,956
|
$28,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.45%
|
39,642
|
$16,000 | — | 30 Jun 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.42%
|
36,799
|
$14,000 | — | 30 Jun 2022 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.23%
|
20,000
|
$8,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.19%
|
16,515
|
$7,000 | — | 30 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.18%
|
15,441
|
$6,000 | — | 30 Jun 2022 | |
| COMMERCE BANK |
13F
|
Company |
0.16%
|
14,280
|
$6,000 | — | 30 Jun 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.16%
|
13,543
|
$5,000 | — | 30 Jun 2022 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.13%
|
11,360
|
$5,000 | — | 30 Jun 2022 | |
| COZAD ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
56,000
|
$23,000 | — | 30 Jun 2022 | |
| DIFESA CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.11%
|
10,000
|
$40,000 | — | 30 Jun 2022 | |
| Johnson Financial Group, Inc. |
13F
|
Company |
0.06%
|
5,500
|
$2,000 | — | 30 Jun 2022 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.06%
|
5,254
|
$2,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
5,000
|
$2,000 | — | 30 Jun 2022 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$1,000 | — | 30 Jun 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.02%
|
2,000
|
$1,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,500
|
$1,000 | — | 30 Jun 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
5
|
$1,000 | — | 30 Jun 2022 | |
| Dov Elefant |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
422,000
|
— | — | 25 Jan 2022 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q3 2022
As of 30 Sep 2022,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
5 shares.
The largest 1 holders included
IFP Advisors, Inc.
This page lists
1
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
24
Q3 2022 holders
1
Holder diff
-23
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.